LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,623,777 | -3.9% | 43,788 | +15.6% | 0.00% | 0.0% |
Q2 2023 | $2,730,571 | +15.0% | 37,872 | -47.6% | 0.00% | 0.0% |
Q1 2023 | $2,374,914 | +16.5% | 72,295 | +136.9% | 0.00% | 0.0% |
Q4 2022 | $2,038,135 | -21.6% | 30,511 | +1.1% | 0.00% | 0.0% |
Q3 2022 | $2,600,000 | +9.5% | 30,189 | +13.4% | 0.00% | 0.0% |
Q2 2022 | $2,375,000 | -10.3% | 26,618 | +13.1% | 0.00% | 0.0% |
Q1 2022 | $2,647,000 | -20.6% | 23,528 | +9.0% | 0.00% | -50.0% |
Q4 2021 | $3,334,000 | +48.2% | 21,583 | +33.6% | 0.00% | +100.0% |
Q3 2021 | $2,250,000 | +13.5% | 16,153 | +6.8% | 0.00% | 0.0% |
Q2 2021 | $1,983,000 | +27.9% | 15,118 | +48.7% | 0.00% | 0.0% |
Q1 2021 | $1,550,000 | +15.7% | 10,168 | -24.5% | 0.00% | 0.0% |
Q4 2020 | $1,340,000 | -39.1% | 13,476 | -41.6% | 0.00% | -50.0% |
Q3 2020 | $2,200,000 | -3.3% | 23,083 | +13.5% | 0.00% | 0.0% |
Q2 2020 | $2,275,000 | +55.0% | 20,338 | +0.7% | 0.00% | 0.0% |
Q1 2020 | $1,468,000 | -13.1% | 20,189 | +24.6% | 0.00% | 0.0% |
Q4 2019 | $1,689,000 | -15.7% | 16,197 | -19.6% | 0.00% | 0.0% |
Q3 2019 | $2,004,000 | -15.7% | 20,134 | -3.3% | 0.00% | -33.3% |
Q2 2019 | $2,377,000 | +6.5% | 20,826 | +17.3% | 0.00% | 0.0% |
Q1 2019 | $2,232,000 | +17.0% | 17,752 | +26.3% | 0.00% | 0.0% |
Q4 2018 | $1,907,000 | +59.4% | 14,050 | +143.1% | 0.00% | 0.0% |
Q2 2018 | $1,196,000 | +23.6% | 5,779 | -2.0% | 0.00% | 0.0% |
Q1 2018 | $968,000 | +5.0% | 5,899 | -12.4% | 0.00% | +50.0% |
Q4 2017 | $922,000 | +1.9% | 6,732 | +1.2% | 0.00% | 0.0% |
Q3 2017 | $905,000 | +27.6% | 6,655 | +13.8% | 0.00% | 0.0% |
Q2 2017 | $709,000 | +16.2% | 5,847 | +1.5% | 0.00% | 0.0% |
Q1 2017 | $610,000 | +10.7% | 5,762 | +5.9% | 0.00% | 0.0% |
Q4 2016 | $551,000 | +12.0% | 5,443 | +12.9% | 0.00% | 0.0% |
Q3 2016 | $492,000 | -18.8% | 4,823 | -5.1% | 0.00% | 0.0% |
Q2 2016 | $606,000 | +17.4% | 5,084 | +5.5% | 0.00% | 0.0% |
Q1 2016 | $516,000 | +19.2% | 4,818 | +20.6% | 0.00% | 0.0% |
Q4 2015 | $433,000 | +50.9% | 3,996 | +19.2% | 0.00% | +100.0% |
Q3 2015 | $287,000 | +39.3% | 3,353 | +63.9% | 0.00% | 0.0% |
Q2 2015 | $206,000 | +795.7% | 2,046 | +373.6% | 0.00% | – |
Q4 2014 | $23,000 | +21.1% | 432 | +7.2% | 0.00% | – |
Q3 2014 | $19,000 | +58.3% | 403 | +111.0% | 0.00% | – |
Q2 2014 | $12,000 | +71.4% | 191 | +87.3% | 0.00% | – |
Q1 2014 | $7,000 | – | 102 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
RK Capital | 174,283 | $8,190,000 | 1.67% |
Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |